Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)
Phase: N/A
Priority: Normal
Start: 02/29/24
End: 03/31/27
Due: 03/31/28
Phase: N/A
Priority: Normal
Start: 05/31/18
End: 03/01/22
Due: 03/01/23
Phase: N/A
Priority: Normal
Start: 04/24/18
End: 09/30/21
Due: 09/30/22
Phase: N/A
Priority: Normal
Start: 12/13/22
End: 11/30/25
Due: 11/30/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015) | NCT06245031 | Cognito Therapeutics, Inc. | user2@example.com | None | 2024-02-29 | 2027-03-31 | 2028-03-31 | - | - | 2025-07-14 |
| Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study) | NCT03661034 | Cognito Therapeutics, Inc. | user2@example.com | None | 2018-05-31 | 2022-03-01 | 2023-03-01 | - | - | 2025-07-14 |
| Multi-Center Study of Sensory Stimulation to Improve Brain Function | NCT03556280 | Cognito Therapeutics, Inc. | user2@example.com | None | 2018-04-24 | 2021-09-30 | 2022-09-30 | - | - | 2025-07-14 |
| A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (Hope Study, CA-0011) | NCT05637801 | Cognito Therapeutics, Inc. | user2@example.com | None | 2022-12-13 | 2025-11-30 | 2026-11-30 | - | - | 2025-07-14 |